A prototypic microfluidic platform generating stepwise concentration gradients for real-time study of cell apoptosis

Area of Science:

• Biomedical Engineering
• Cell Biology
• Microfluidics

Background:

• Apoptosis is a critical cellular process often studied using drug treatments.
• Traditional methods for drug gradient generation and apoptosis analysis can be time-consuming and require large sample volumes.

Purpose of the Study:

• To develop a novel microfluidic platform for generating stepwise drug concentration gradients.
• To integrate a sensitive apoptosis detection method for high-throughput analysis of drug effects on cells.

Main Methods:

• Development of a prototypic microfluidic chip with integrated valves for precise drug gradient generation.
• Incorporation of a Förster Resonance Energy Transfer (FRET)-based assay to monitor caspase-3 activation, an indicator of apoptosis.
• Parallel culture and analysis of HeLa cells exposed to etoposide concentration gradients within the microfluidic system.
• Comparison of microfluidic results with traditional 96-well plate assays and MTT assays.

Main Results:

• The microfluidic platform successfully generated stepwise concentration gradients of etoposide.
• The integrated FRET-based assay provided sensitive and real-time monitoring of apoptosis.
• High-throughput analysis of etoposide's apoptotic effects on HeLa cells was achieved.
• On-chip results correlated well with conventional assay methods.

Conclusions:

• The developed microfluidic platform offers a high-throughput, sensitive, and low-drug-consumption method for studying drug-induced apoptosis.
• This system provides a valuable tool for drug screening and mechanistic studies in cell biology.
• Microfluidic technology demonstrates significant advantages over traditional methods for complex cellular assays.